CRPS Clinical Trial
Official title:
Etanercept for the Treatment of Chronic Regional Pain Syndrome
Studying the effects of Etanercept (an anti-Tumor Necrosis Factor alpha) on early Chronic Regional Pain Syndrome (CRPS). Our hypothesis is that Etanercept will improve patient symptoms if given in early CRPS.
n/a
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT00377468 -
Effect of Delta-9-Tetrahydrocannabinol on the Prevention of Chronic Pain in Patients With Acute CRPS (ETIC-Study)
|
Phase 2 | |
Completed |
NCT01618578 -
The Rubber Hand Illusion (RHI) in Patients With CRPS
|
N/A | |
Completed |
NCT02467556 -
Psychological Intervention and Physiotherapy With Medication Improves CRPS Patients Outcome
|
Phase 4 | |
Recruiting |
NCT01601925 -
Distances From Cricoid Cartilage to the Targets of Stellate Ganglion Block
|
N/A | |
Withdrawn |
NCT04709757 -
Comparison of Continuous and Burst High Frequency Spinal Cord Stimulation Paradigms
|
N/A | |
Completed |
NCT00558753 -
Prospective, Randomized Controlled Trial on Perioperative Pregabalin to Reduce Late-onset CRPS After TKA
|
Phase 2 | |
Active, not recruiting |
NCT05473338 -
Complex Regional Pain Syndrome (CRPS) and the Gut-bacteria
|